Our Services
Medical Information
Helpful Resources
Published on: 5/6/2026
Are peptides safe during pregnancy? Current evidence on supplemental peptides in pregnancy is extremely limited, and experts warn of potential risks including hormonal imbalance, immune modulation, unknown effects on fetal development, and supplement quality control concerns. Most health authorities recommend discontinuing nonessential peptides during pregnancy and instead focusing on prenatal vitamins, balanced nutrition, and safe, evidence-based alternatives. Always discuss any supplement use with your healthcare provider.
Because safety depends on individual factors like your trimester, existing symptoms, and overall health, a personalized assessment matters. If you're experiencing any unusual symptoms or want clarity on your next steps, take a free, instant, online symptom check to better understand what's going on and how to move forward safely.
Reviewed for medical accuracy: 07/09/2026
Peptides While Pregnant? The Safety Risks and Medically Approved Next Steps
Pregnancy is a time when many women rethink supplements, medications and wellness routines. Peptides—short chains of amino acids—have become popular for skin health, muscle recovery and hormone support. But what does current evidence say about peptides while pregnant? Below, we'll break down the basics, potential risks, and medically approved next steps.
Peptides are naturally occurring molecules in the body that signal cells to perform certain functions. In supplemental form, they can:
Although many non‐pregnant adults report cosmetic or performance benefits, research on their safety in pregnancy is virtually nonexistent.
Your body undergoes dramatic hormonal, metabolic and cardiovascular changes during pregnancy. Because of this:
Most peptide studies focus on post‐menopausal women, athletes or the elderly—not pregnant people. As a result, data on "peptides while pregnant" is extremely limited.
Without pregnancy‐specific trials, experts weigh theoretical risks based on peptide actions:
Because of these risks, most health authorities recommend avoiding any nonessential compounds without clear safety data.
While there's no peptide‐specific pregnancy guideline, general rules apply:
In practice, that means peptides generally fall into the "avoid" category unless you're enrolled in a controlled clinical trial.
If you're already using peptides and become pregnant, stop immediately. Watch for:
If you notice any of these warning signs, you can quickly check your symptoms with Ubie's free AI symptom checker to understand what might be happening and whether you need to contact your doctor right away.
Stop Nonessential Peptides
Discontinue any peptide you don't absolutely need. Pregnancy isn't the time for experimental therapies.
Focus on Pregnancy‐Safe Nutrition
Discuss Medications and Supplements with Your Doctor
Monitor Key Health Metrics
Consider Evidence‐Based Alternatives
Some symptoms require prompt medical attention:
Always speak to a doctor if you experience anything that feels life threatening or serious.
After delivery and once you've finished breastfeeding, you can revisit peptide use—provided you:
Pregnancy is a time to prioritize proven, evidence‐based care. If you have questions about medications, supplements or any worrisome symptoms, speak to a doctor. Your medical team can guide you toward the safest choices for you and your baby.
(References)
* Pires, A.M., Ravasco, P., & Camelo, A. (2023). Collagen supplements for pregnant and lactating women: are they safe and beneficial? *Molecules*, 28(20), 7127. PMID: 37894218. DOI: 10.3390/molecules28207127.
* Kominiarek, M.A., & Rajan, P. (2016). Dietary supplements during pregnancy: A critical review of maternal, fetal, and offspring safety. *American Journal of Obstetrics and Gynecology*, 214(5), 585-594. PMID: 26527581. DOI: 10.1016/j.ajog.2015.10.052.
* Schaefer, C., Schuler, A., Rieder, M.J., & Kennedy, D.L. (2023). Medication use during pregnancy and lactation: An overview of risk assessment and available resources. *British Journal of Clinical Pharmacology*, 89(6), 1836-1845. PMID: 36720760. DOI: 10.1111/bcp.15682.
* Cohen, P.A. (2014). Unregulated dietary supplements and potential harm to vulnerable populations. *Journal of General Internal Medicine*, 29(1), 193-194. PMID: 24043681. DOI: 10.1007/s11606-013-2615-5.
* Knopp, R.H., & Schaefer, C. (2009). The use of experimental drugs in pregnancy: a challenge for regulatory agencies and clinicians. *Clinical Pharmacology & Therapeutics*, 85(1), 3-5. PMID: 19078709. DOI: 10.1038/clpt.2008.232.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.